ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1071

Rapid Access Microscopy and Real Time Case Discussion via a Secure Messaging App Improves Diagnostic Accuracy and Management of Acute Hot Swollen Joints

Anouchka Lewis1, John Stack2, Oisin Corish2, Callum Swift2, Tomás Breslin2, Frank Lyons2, Eavan Muldoon2, Cian McDermott2, Sharon Cowley2, Helina Alemayehu2, Oliver Boughton2, Khaled Taha2 and Geraldine McCarthy2, 1The Mater Misericordiae University Hospital, Dublin, Ireland, 2Mater Misericordiae University Hospital, Dublin, Ireland

Meeting: ACR Convergence 2024

Keywords: Crystal-induced arthritis, Diagnostic criteria, gout, pseudogout, quality of care

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 17, 2024

Title: Measures & Measurement of Healthcare Quality Poster

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: Patients with acute swollen joints are often presumed to have septic arthritis, leading to treatment with intravenous antibiotics and arthroscopic washout. Previously at our centre, joint fluid aspirates often lacked crystal analysis resulting in excess culture negative septic arthritis diagnoses. To address this, stakeholders from the emergency department (ED), infectious disease, orthopaedic, and rheumatology services developed a ‘Hot Joint Pathway’. We hypothesised that since acute crystal arthropathy can be misdiagnosed as ‘culture-negative septic arthritis’, introducing the pathway would increase diagnostic accuracy and decrease unnecessary admissions, intravenous antibiotics and joint washouts.

 

Methods: A “Hot Joint Pathway” was developed to provide a structured approach for investigating acutely swollen joints, outlining necessary blood tests, sepsis assessment, indications for joint aspiration and guidance on distinguishing septic arthritis from other conditions such as crystal arthritis. Key features of the pathway include a secure messaging app for multidisciplinary discussion and rheumatology-led rapid access polarized light microscopy (PLM) within 24 hours. A service evaluation, approved by our clinical audit committee, was completed following the pathway’s introduction. Hospital inpatient data from the Mater Misericordiae University Hospital, Dublin, identified patients labelled with septic arthritis (including culture negative cases) discharged between two periods: before the pathway (01/01/2019 to 30/11/2020) and after its introduction (22/09/2022 to 21/02/2024). Data were also recorded for patients presenting with an acute swollen joint at the ED who were subsequently discussed on the secure messaging app between 27/09/2022 and 25/09/2023. Patient medical records, laboratory results, and radiology reports were reviewed. 

 

Results: Of the patients discussed on the secure messaging app who presented to the ED,  92% received rheumatology input, and 100% underwent joint aspiration with crystal analysis by a rheumatologist in less than 24 hours. 68% of patients avoided hospital admission, receiving same-day discharge. Of these 53% received a same day  diagnoses of crystal arthropathy and were discharged with a plan for rheumatology outpatient follow-up. Diagnostic accuracy increased substantially following introduction of the pathway (Table 1). Joint aspirates increased from 50% to 76%. Culture negative cases of septic arthritis reduced from 34% to 17%. Culture positive cases of septic arthritis increased from 41% to 76%. Crystal analysis increased from 19% to 28%. Positive blood cultures increased from 28% to 41%. Average length of stay reduced by 6 days.

 

Conclusion: A structured care pathway combining rheumatology-led rapid access PLM and multidisciplinary case discussion via a secure messaging app increases diagnostic accuracy for patients presenting with acute swollen joints. This pathway facilitates admission avoidance, reduces length of stay, and prevents unnecessary surgical intervention, whilst positively impacting antimicrobial stewardship. Access to rheumatology-led point-of-care PLM is essential to the success of this pathway.

Supporting image 1

Table 1: Positive Blood Cultures, Joint Aspirations, Crystal Analyses and Culture Positive and Negative Septic Arthritis Cases Pre and Post Introduction of the “Hot Joint Pathway”.

Supporting image 2

Figure 1: Culture Positive Versus Negative Cases of Septic Arthritis Pre and Post Pathway.

Supporting image 3

Figure 2: Cases Admitted versus Discharged with Same Day Diagnoses from the Emergency Department. CPPD – calcium pyrophosphate deposition disease, OA – osteoarthritis.


Disclosures: A. Lewis: None; J. Stack: None; O. Corish: None; C. Swift: None; T. Breslin: None; F. Lyons: None; E. Muldoon: None; C. McDermott: None; S. Cowley: None; H. Alemayehu: None; O. Boughton: None; K. Taha: None; G. McCarthy: None.

To cite this abstract in AMA style:

Lewis A, Stack J, Corish O, Swift C, Breslin T, Lyons F, Muldoon E, McDermott C, Cowley S, Alemayehu H, Boughton O, Taha K, McCarthy G. Rapid Access Microscopy and Real Time Case Discussion via a Secure Messaging App Improves Diagnostic Accuracy and Management of Acute Hot Swollen Joints [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/rapid-access-microscopy-and-real-time-case-discussion-via-a-secure-messaging-app-improves-diagnostic-accuracy-and-management-of-acute-hot-swollen-joints/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/rapid-access-microscopy-and-real-time-case-discussion-via-a-secure-messaging-app-improves-diagnostic-accuracy-and-management-of-acute-hot-swollen-joints/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology